Joel R. Rathbun - 17 Feb 2023 Form 4 Insider Report for AVIENT CORP (AVNT)

Signature
/s/ Lisa K. Kunkle, Power of Attorney For: Joel R. Rathbun
Issuer symbol
AVNT
Transactions as of
17 Feb 2023
Net transactions value
$0
Form type
4
Filing time
21 Feb 2023, 10:54:44 UTC
Previous filing
14 Feb 2023
Next filing
08 Sep 2023

Sponsored

Quoteable Key Fact

"Joel R. Rathbun filed Form 4 for AVIENT CORP (AVNT) on 21 Feb 2023."

Quick Takeaways

  • This page summarizes Joel R. Rathbun's Form 4 filing for AVIENT CORP (AVNT).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Filing timestamp: 21 Feb 2023, 10:54.

What Changed

  • Previous filing in this sequence was filed on 14 Feb 2023.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVNT Restricted Stock Units Award $0 +6,850 $0.000000 6,850 17 Feb 2023 Common Stock 6,850 Direct F1
transaction AVNT Stock Appreciation Rights Award $0 +23,250 $0.000000 23,250 17 Feb 2023 Common Stock 23,250 $42.93 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Avient common stock.
F2 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of twenty consecutive trading days) from the grant date closing price of $42.93 per share and no more than one-third of the grant can vest per year during the first three years.